BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 2503586)

  • 1. Variability among brain regions in the specificity of 6-hydroxydopamine (6-OHDA)-induced lesions.
    Commins DL; Shaughnessy RA; Axt KJ; Vosmer G; Seiden LS
    J Neural Transm; 1989; 77(2-3):197-210. PubMed ID: 2503586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Magnitude and duration of hyperactivity following neonatal 6-hydroxydopamine is related to the extent of brain dopamine depletion.
    Miller FE; Heffner TG; Kotake C; Seiden LS
    Brain Res; 1981 Dec; 229(1):123-32. PubMed ID: 6796194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of hyperactivity in adult rats induced by neonatal intraventricular 6-hydroxydopamine following pargyline or desmethylimipramine treatment.
    Olds ME; Yuwiler A
    Psychopharmacology (Berl); 1985; 87(4):484-9. PubMed ID: 3936107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on brain monoamine and neuropeptide systems after neonatal intracerebroventricular 6-hydroxydopamine treatment.
    Luthman J; Brodin E; Sundström E; Wiehager B
    Int J Dev Neurosci; 1990; 8(5):549-60. PubMed ID: 1704172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Possible involvement of serotonergic neurons in the reduction of locomotor hyperactivity caused by amphetamine in neonatal rats depleted of brain dopamine.
    Heffner TG; Seiden LS
    Brain Res; 1982 Jul; 244(1):81-90. PubMed ID: 6288184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Central noradrenergic involvement in yohimbine excitation of acoustic startle: effects of DSP4 and 6-OHDA.
    Kehne JH; Davis M
    Brain Res; 1985 Mar; 330(1):31-41. PubMed ID: 3921192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Noradrenergic lesions differentially alter the expression of two subtypes of low Km cAMP-sensitive phosphodiesterase type 4 (PDE4A and PDE4B) in rat brain.
    Farooqui SM; Zhang K; Makhay M; Jackson K; Farooqui SQ; Cherry JA; O'Donnell JM
    Brain Res; 2000 Jun; 867(1-2):52-61. PubMed ID: 10837797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of modification of brain serotonin (5-HT), norepinephrine (NE) and dopamine (DA) on ethanol tolerance.
    Lê AD; Khanna JM; Kalant H; LeBlanc AE
    Psychopharmacology (Berl); 1981; 75(3):231-5. PubMed ID: 6798612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microdialysates of amines and metabolites from core nucleus accumbens of freely moving rats are altered by dizocilpine.
    Hatip-Al-Khatib I; Mishima K; Iwasaki K; Fujiwara M
    Brain Res; 2001 May; 902(1):108-18. PubMed ID: 11376600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stimulated serotonin release from hyperinnervated terminals subsequent to neonatal dopamine depletion regulates striatal tachykinin, but not enkephalin gene expression.
    Basura GJ; Walker PD
    Brain Res Mol Brain Res; 2000 Sep; 81(1-2):80-91. PubMed ID: 11000480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rotational behavior induced by 8-hydroxy-DPAT, a putative 5HT-1A agonist, in 6-hydroxydopamine-lesioned rats.
    Gerber R; Altar CA; Liebman JM
    Psychopharmacology (Berl); 1988; 94(2):178-82. PubMed ID: 2965396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The development of brain biogenic amines, cyclic nucleotides and hyperactivity in 6-OHDA-treated rat pups.
    Concannon JT; Braughler JM; Schechter MD
    Pharmacol Biochem Behav; 1983 Apr; 18(4):477-82. PubMed ID: 6306694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Age-dependent effects of 6-hydroxydopamine on locomotor activity in the rat.
    Erinoff L; MacPhail RC; Heller A; Seiden LS
    Brain Res; 1979 Mar; 164():195-205. PubMed ID: 427556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regional depletion of central nervous system catecholamines: effects on blood pressure and drinking behavior.
    Gordon FJ; Brody MJ; Johnson AK
    Brain Res; 1985 Oct; 345(2):285-97. PubMed ID: 3930004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of low doses of intracerebroventricular 6-OHDA on the levels of monoaminergic neurotransmitters in rat brain structures.
    Sadakierska-Chudy A; Haduch A; Gołembiowska K; Daniel WA
    Pharmacol Rep; 2010; 62(6):1225-30. PubMed ID: 21273682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alteration of seizures resulting from pinealectomy in the rat after neonatal treatment with 6-hydroxydopamine.
    Stockmeier CA; Larsen BR; Blask DE
    J Neurosci Res; 1985; 14(2):279-84. PubMed ID: 3930758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A two-population model of rat rotational behavior: effects of unilateral nigrostriatal 6-hydroxydopamine on striatal neurochemistry and amphetamine-induced rotation.
    Shapiro RM; Glick SD; Camarota NA
    Brain Res; 1987 Nov; 426(2):323-31. PubMed ID: 2446711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amphetamine and LSD as discriminative stimuli: alterations following neonatal monoamine reductions.
    Minnema DJ; Rosecrans JA
    Pharmacol Biochem Behav; 1984 Jan; 20(1):95-101. PubMed ID: 6420809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neonatal intraspinal 6-hydroxydopamine, 5,7-dihydroxytryptamine or their combination: effects on nociception and morphine analgesia.
    Pappas B; Ings R; Roberts D
    Eur J Pharmacol; 1982 Dec; 86(2):157-66. PubMed ID: 6819155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective lesions by manganese and extensive damage by iron after injection into rat striatum or hippocampus.
    Sloot WN; van der Sluijs-Gelling AJ; Gramsbergen JB
    J Neurochem; 1994 Jan; 62(1):205-16. PubMed ID: 7505311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.